✦ LIBER ✦

The clinical pharmacology of VM26 and VP16-213

✍ Scribed by Patrick J. Creaven

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The podophyllotoxin derivatives VP16-213

✍ Brian F. Issell 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 711 KB

VM 26 and VP 16–213: A comparative analy

✍ Marcel Rozencweig; Daniel D. Von Hoff; Jane E. Henney; Franco M. Muggia 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 805 KB

Pharmacokinetics of teniposide (VM26) an

✍ William E. Evans; Joseph A. Sinkule; William R. Crom; Lois Dow; A. Thomas Look; 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 328 KB

Etoposide (VP16-213) and teniposide (VM2

✍ Brian F. Issell; Claude Tihon; M. Elaine Curry 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 247 KB

Clinical trial of CPT-11 and VM-26/VP-16

✍ Lynn G. Feun; Angela Marini; Howard Landy; Arnold Markoe; Deborah Heros; Carlos 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 126 KB

Determination of etoposide (VP16-213) an

✍ James M. Rideout; David C. Ayres; C.K. Lim; T.J. Peters 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 296 KB